• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐多药和广泛耐药结核病:欧盟及欧洲经济区的一个持续存在的问题。

Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area.

机构信息

Surveillance Unit, Tuberculosis Programme, European Centre for Disease Prevention and Control, Stockholm, Sweden.

出版信息

Euro Surveill. 2010 Mar 18;15(11):19519.

PMID:20338147
Abstract

Since 2008, the European Centre for Disease Prevention and Control has been collecting data from the European Union (EU) and European Economic Area (EEA) on resistance to first- and second-line drugs against tuberculosis (TB). In 2008, the proportion of multidrug-resistant tuberculosis (MDR TB) was 6.0% of the total case load for 25 countries reporting data. Extensively drug-resistant (XDR TB) reporting has increased since 2007 and was observed in 7.3% of the MDR TB cases in 13 reporting countries. MDR TB remains a threat and XDR TB is now established within the EU/EEA borders.

摘要

自 2008 年以来,欧洲疾病预防控制中心一直在收集欧盟(EU)和欧洲经济区(EEA)关于结核病(TB)一线和二线药物耐药的数据。2008 年,25 个报告数据的国家的总病例负荷中,耐多药结核病(MDR-TB)的比例为 6.0%。自 2007 年以来,广泛耐药结核病(XDR-TB)的报告有所增加,在 13 个报告国家的 MDR-TB 病例中观察到 7.3%。MDR-TB 仍然是一个威胁,XDR-TB 现在已经在欧盟/EEA 边境建立。

相似文献

1
Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area.耐多药和广泛耐药结核病:欧盟及欧洲经济区的一个持续存在的问题。
Euro Surveill. 2010 Mar 18;15(11):19519.
2
Surveillance of extensively drug-resistant tuberculosis in Europe, 2003-2007.2003-2007 年欧洲广泛耐药结核病监测。
Euro Surveill. 2010 Mar 18;15(11):19518.
3
Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control.耐多药和广泛耐药结核病在西方。欧洲和美国:流行病学、监测和控制。
Clin Chest Med. 2009 Dec;30(4):637-65, vii. doi: 10.1016/j.ccm.2009.08.015.
4
Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.欧盟的耐药结核病:控制的机遇与挑战。
Tuberculosis (Edinb). 2010 May;90(3):182-7. doi: 10.1016/j.tube.2010.03.008. Epub 2010 Apr 10.
5
Extensively drug-resistant tuberculosis in california, 1993-2006.1993 - 2006年加利福尼亚州的广泛耐药结核病
Clin Infect Dis. 2008 Aug 15;47(4):450-7. doi: 10.1086/590009.
6
Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance data.世界卫生组织欧洲区域耐多药结核病:监测数据分析。
Drug Resist Updat. 2013 Dec;16(6):108-15. doi: 10.1016/j.drup.2014.02.003. Epub 2014 Feb 28.
7
Extensively drug-resistant (XDR) tuberculosis: an old and new threat.广泛耐药结核病:一种新老威胁并存的疾病
Ann Ist Super Sanita. 2007;43(4):317-9.
8
Clinical and operational value of the extensively drug-resistant tuberculosis definition.广泛耐药结核病定义的临床及操作价值
Eur Respir J. 2007 Oct;30(4):623-6. doi: 10.1183/09031936.00077307. Epub 2007 Aug 9.
9
Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study.广泛耐药结核病患者中的广泛耐药结核病患病率:一项基于医院的回顾性研究。
Indian J Med Res. 2009 Oct;130(4):392-5.
10
Population-based surveillance of extensively drug-resistant tuberculosis in Shandong Province, China.中国山东省基于人群的广泛耐药结核病监测。
Int J Tuberc Lung Dis. 2012 May;16(5):612-4. doi: 10.5588/ijtld.11.0507. Epub 2012 Mar 7.

引用本文的文献

1
First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017.2008-2017 年德国一线抗结核药物耐药模式及相关危险因素。
PLoS One. 2019 Jun 12;14(6):e0217597. doi: 10.1371/journal.pone.0217597. eCollection 2019.
2
Factors associated with unreported tuberculosis cases in Spanish hospitals.西班牙医院中未报告结核病病例的相关因素。
BMC Infect Dis. 2015 Jul 29;15:295. doi: 10.1186/s12879-015-1047-0.
3
Comparing microspheres with different internal phase of polyelectrolyte as local drug delivery system for bone tuberculosis therapy.
比较具有不同聚电解质内相的微球作为骨结核治疗的局部给药系统。
Biomed Res Int. 2014;2014:297808. doi: 10.1155/2014/297808. Epub 2014 Feb 23.
4
Tuberculosis treatment outcome monitoring in European Union countries: systematic review.欧盟国家结核病治疗结局监测:系统评价。
Eur Respir J. 2013 Mar;41(3):635-43. doi: 10.1183/09031936.00030612. Epub 2012 Jul 12.
5
Survival of drug resistant tuberculosis patients in Lithuania: retrospective national cohort study.立陶宛耐药结核病患者的生存情况:全国性回顾性队列研究。
BMJ Open. 2011 Nov 28;1(2):e000351. doi: 10.1136/bmjopen-2011-000351. Print 2011.
6
Multidrug and extensively drug-resistant tuberculosis from a general practice perspective.全科视角下的耐多药和广泛耐药结核病。
Infect Drug Resist. 2010;3:115-22. doi: 10.2147/IDR.S10743. Epub 2010 Oct 22.